How to Out-Scout Your Rivals and Dominate the Territory
On the surface, the NFL draft and the field engagement of Healthcare Professionals (HCPs) might seem worlds apart, but the strategy for building a championship team is exactly the same. And remember the goal: win market share.
Field reps are routinely directed by management to focus relentlessly on the Decile-9 and Decile-10 doctors. Much like the early first round of the NFL draft, these HCPs are the consensus blue-chip targets because of their massive historical prescription volumes. And yes, you must engage with them to secure key physician relationships.
But if you want to outmaneuver your competition, your pipeline needs to focus on the “later rounds:” Deciles 5 through 8.
Access Over the Obvious (The Decile 10 Trap)
Those high-decile doctors are almost entirely “no-see” engagements. While your competitors are parking their reps in the exact same crowded waiting rooms, fighting for 10 seconds of hallway time, you are wasting valuable labor. It is a competitive trap. Mandating high call frequencies on these saturated targets often reduces your reps to “human spam,” relying on outdated “samples, slogans, and sandwiches” just to get in the door.
To win, you must realize that a high-volume doctor is useless to your quota if they are completely inaccessible or deeply entrenched as a loyalist to your rival’s brand.
Exploiting the Hidden Upside
A winning strategy in who to target is about finding the draft steals. In pharma sales, these are the “undiscovered” (Decile 4, 5, or 6) doctors who may currently have lower overall volume but are highly progressive, brand-agnostic, and actually have the accessibility and time to sit down to discuss patient outcomes.
High-decile HCPs are often maxed out on their prescribing capacity, but lower-decile HCPs offer massive, untapped growth potential. Are they all going to be a perfect fit? No. But while your competitors are ignoring them, your reps can secure their loyalty early and lock down the territory.
The “Decile+” Competitive Edge
Just because you lack the historical volume data on these unknown HCPs doesn’t mean there is no potential. You just have to rely on a superior scouting engine. By upgrading from static, volume-only databases to Decile+ targeting, you arm your team with dynamic, multi-dimensional intelligence.
This allows your reps to prioritize targets based on true accessibility, the size of their relevant patient pool, and their lack of loyalty to competitor brands. This data-driven agility provides a massive competitive edge, allowing you to strike new potential revenue points.
If You Only Throw Hail Marys, You’ll Starve
A healthy mix of HCPs is like having a balanced portfolio. You want to build an unstoppable sales machine that doesn’t just chase the “fool’s gold” of pure volume. You must inspire your sales team to stop checking CRM boxes and start outsmarting the field as strategic clinical consultants.
By balancing the consensus blue-chip targets with accessible, high-potential mid-rounders, you ensure a dominant pipeline that continuously steals market share from your rivals.